Richard Barry, Director at Sarepta Therapeutics, Inc. (SRPT), bought 10,000 shares at $87.49 ($875K) on 2019-09-12, disclosed to the SEC on 2019-09-16.
Open-market purchase of $875k SRPT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.49 | 1,691 | $148K | 16.9% |
| 2 | $87.49 | 1,691 | $148K | 16.9% |
| 3 | $87.49 | 3,309 | $290K | 33.1% |
| 4 | $87.49 | 3,309 | $290K | 33.1% |
| Total | $87.49 avg | 10,000 | $875K | 100% |
| Filing → |
| SAVA | BUY | 2025-11-24 | $828K | — | Filing → |
| SAVA | BUY | 2025-11-20 | $404K | — | Filing → |
| SAVA | BUY | 2025-09-23 | $16K | — | Filing → |